BTK and colitis: Mechanistic insights from previous studies have also highlighted impaired production of type I and III interferons in XLA patients following enteroviral infections (18), as well as dysregulated IL-1β signaling and NLRP3 inflammasome hyperactivation in BTK-deficient colitis models (19).